News | Robotic Systems | October 25, 2016

New Jersey Physician Surpasses 500 Procedures Using Stereotaxis Niobe System

Physicians at Robert Wood Johnson University Hospital have used remote magnetic navigation system in more than 1,500 procedures to date, the most of any hospital in North America

Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures

October 25, 2016 — Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed more than 500 cardiac ablation procedures using the Niobe remote magnetic navigation system. Younan currently leads the Northeast region in catheter ablations performed using the Niobe system in the six-and-a-half years since installation.

RWJUH, a Cardiovascular Center of Excellence and the principal teaching hospital of the Rutgers Robert Wood Johnson Medical School in New Brunswick, N.J. first installed the Niobe system in 2010 and upgraded to the Niobe ES system in early 2012. Since that time, the electrophysiology lab has increased its patient caseload, through shorter procedure times, and by attracting more patients with a wide range of complex heart arrhythmias. 

Collectively, the physicians of RWJUH have utilized Stereotaxis remote magnetic navigation technology in more than 1,500 procedures to date, more than any other hospital in North America from 2010 to present.

“Stereotaxis technologies are amazing innovations, and the contrasts with traditional methods are striking,” said Younan. “With the remote magnetic navigation and detailed mapping tools of the Niobe system, we are able to navigate the ablation catheter more quickly, safely, and precisely — even in hard-to-reach regions of the heart. As a result, we see decreased radiation exposure, lower risk of complications and higher success rates, particularly for challenging procedures such as ventricular tachycardia. I believe this system will eventually become the gold standard in cardiac ablations.”    

“Stereotaxis provides yet another advanced treatment approach that is available to cardiac patients at RWJUH,” said Michael Antoniades, President and CEO of Robert Wood Johnson University Hospital.  “Our team has a well-earned reputation for expanding the boundaries of medicine while delivering cutting-edge, quality care to patients.”

For more information: www.stereotaxis.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init